Anne P. Døskeland

Expression of recombinant human phenylalanine hydroxylase as fusion protein in <i>Escherichia coli</i> circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme

P.M. Knappskog, Sigríður Ólafsdóttir, Anne P. Døskeland et al. · Biochemical Journal · 1995 · 182 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells

Camilla Stapnes, Anne P. Døskeland, Kimberley Joanne Hatfield et al. · British Journal of Haematology · 2007 · 118 citations · Full text

Medicine, Hematology, Pharmacology +15

Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo

Salwa Suliman, Zhe Xing, Xujun Wu et al. · Journal of Controlled Release · 2014 · 116 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzyme.

Anne P. Døskeland, Stein Ove Døskeland, Torgeir Flatmark · Journal of Biological Chemistry · 1984 · 73 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Phosphorylation of recombinant human phenylalanine hydroxylase: effect on catalytic activity, substrate activation and protection against non-specific cleavage of the fusion protein by restriction protease

Anne P. Døskeland, Aurora Martı́nez, Per M. Knappskog et al. · Biochemical Journal · 1996 · 61 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17